Contagion&reg Editorial Staff

Jason M. Pogue, PharmD, discusses the challenges clinicians face when dosing beta-lactams based on the current guidelines.

In case you missed them, we've compiled the top 5 articles from this past week.

Bruce A. Mueller, PharmD, shares how clinicians in the inpatient setting can quantify acute kidney injury in adults on antibiotics.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Joseph Eron, MD, explains how integrase inhibitors have dramatically changed HIV therapy for the better.

Julia E. Szymczak, PhD, shares the results of her study which revealed that fear drives some clinicians to prescribe inappropriately.

Colleen Kelley, MD, describes the role of health care providers in linking patients with PrEP.

The US Food and Drug Administration (FDA) approved this new intravenously-administered HIV medication for patients who are suffering from multidrug-resistant HIV who have failed other antiretroviral therapies.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

In case you missed them, we’ve compiled a list of the latest recalls issued by the FDA and USDA.

Mike Kohut, PhD shares the results of his research that reveals providers are writing prescriptions for infections based largely on patient demand and not guideline recommendations.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Emil Lesho, DO, FACP, FIDSA, FSHEA, explains what makes Elizabethkingia unique.

Contagion® Editorial Advisory Board member, James S. Lewis, PharmD, FIDSA, shares how antibiotic stewards can craft stewardship interventions to their own reality.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Contagion® will be covering the conference, and so, keep a look out for session coverage as well as interviews with some of the key presenters.

Joseph Eron, MD, discusses benefits of long-acting injectable antiretroviral therapy as well as misconceptions.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

Paratek’s omadacycline moves another step toward approval.

The risk comes after it was found that surgical instruments used for orthopedic and spine surgeries were not cleaned properly and consequently, the sterilization of those instruments was compromised.

Barley Chironda, RPN, CIC, explains the role that nurses play in disinfection practices at health care facilities.

Dr. Tomlinson previously served as the principal deputy director for the DGHT and became the Acting Director in October 2017.

These recommendations come on the heels of a review of the vaccine by the WHO’s Strategic Advisory Group of Experts on Immunization in October 2017.

Marin H. Kollef, MD, discusses new therapies in development for the treatment of Pseudomonas infections.

The results of a new analysis presented at the 47th Critical Care Congress reveal that incidence of intensive care unit (ICU) bacteremia is decreasing over time.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.